PRP Alliance

PRP Alliance

Diagnosing PRP

PRP Alliance to Update 2013 Biopsy Poll

From the Editors: During the summer of 2013, a total of 487 PRP patients were polled by email and given an opportunity to participate in a first-of-its-kind PRP Biopsy Poll. Remarkably, within a 3-week period, a total of 256 invitees (52.6%) shared their biopsy experiences and/or recollections.The primary objective of the PRP Biopsy Poll was to better understand […]

PRP Alliance to Update 2013 Biopsy Poll Read More »

Pityriasis Rubra Pilaris Draft for NORD

ACKNOWLEDGMENT NORD gratefully acknowledges the following for their assistance in preparing this report: Mark Lebwolh MD, Chairman, Dermatology Department,  Icahn Medical School, Mount Sinai Hospital, New York, NY; Jouni Uitto MD, PhD Professor and Chair, Department of Dermatology and Cutaneous Biology. Thomas Jefferson University, Philadelphia, PA; Nicholas A Ross, MD, Lead Investigator and Resident Physician,

Pityriasis Rubra Pilaris Draft for NORD Read More »

PRP Awareness Month

From the Editor… My first PRP Awareness Day was November 28, 2012 and quite “unofficial” by any standards. It began with a phone call from my dermatologist’s office. I was told that the appearance of a red spot on my forehead on August 8 — nearly four months prior — had been the onset of pityriasis rubra pilaris. Like

PRP Awareness Month Read More »

PRP and Diagnostic Coding

From the Editor… When the clinical observations of a dermatologist are supported by a biopsy prepared by a dermatopathologist, a diagnosis of pityriasis rubra pilaris is  rendered and the diagnostic code L44.0 entered into the patient’s medical record. The International Classification of Diseases (ICD) is an essential element in every medical record. The ICD code is important for health insurance reimbursement, administration, epidemiology (the

PRP and Diagnostic Coding Read More »